Related Experiment Video
Updated: Sep 16, 2025
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
8.2K
Hypercholesterolemia of Cholestasis
Maxwell Charlat1, Elona Poltiyelova1, Jesse Silverman1
1From the Department of Internal Medicine.
Cardiology in Review
|July 11, 2025
Summary
Primary biliary cholangitis (PBC) causes high cholesterol but not increased cardiovascular risk. Measuring apolipoprotein B helps manage PBC hypercholesterolemia with statins or PCSK9 inhibitors.
Area of Science:
- Biochemistry
- Hepatology
- Cardiology
Background:
- Cholesterol homeostasis is vital, regulated by low-density lipoprotein (LDL) transport.
- Elevated LDL cholesterol is linked to atherosclerotic cardiovascular disease.
- Cholestatic liver diseases, like primary biliary cholangitis (PBC), disrupt cholesterol balance.
Purpose of the Study:
- To investigate hypercholesterolemia in PBC.
- To clarify cardiovascular risk in PBC patients.
- To identify optimal methods for managing PBC-related hypercholesterolemia.
Main Methods:
- Analysis of cholesterol metabolism in PBC.
- Evaluation of cardiovascular risk factors in PBC.
- Assessment of diagnostic biomarkers like Lipoprotein X and apolipoprotein B.
- Review of therapeutic strategies including statins and PCSK9 inhibitors.
Main Results:
- PBC involves impaired hepatocyte cholesterol clearance, reduced bile synthesis, and increased cholesterol production.
- Lipoprotein X is a specific cholestasis biomarker, sometimes causing extreme hypercholesterolemia.
- PBC hypercholesterolemia correlates with poorer liver outcomes but not higher atherosclerotic cardiovascular disease risk.
- Apolipoprotein B measurement is the most accurate method for cardiovascular risk stratification in PBC.
Conclusions:
- Patients with PBC experience hypercholesterolemia due to liver dysfunction, not direct cardiovascular risk.
- Apolipoprotein B is the key biomarker for assessing cardiovascular risk in PBC.
- Statins and PCSK9 inhibitors are effective treatments for hypercholesterolemia in cholestatic liver disease.
- Regular monitoring of apolipoprotein B levels is essential to gauge treatment efficacy.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
697
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
697
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
879
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
879
01:26Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
01:16Hepatic Drug Excretion: Influencing Factors
231
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
231
01:28Overview of Fatty Acid Metabolism
31.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
31.7K
01:18Lipids: Dietary Sources and Requirements
1.1K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.1K